Cargando…
The costimulatory receptor B7-1 is not induced in injured podocytes
Recent research on podocytes has proposed B7-1 as an important player in podocyte biology and as a potential new therapeutic target. B7-1 was upregulated in injured podocytes and described as a biomarker to identify patients who may benefit from abatacept, a B7-1 blocker. However, after this initial...
Autores principales: | Baye, Emilie, Gallazzini, Morgan, Delville, Marianne, Legendre, Christophe, Terzi, Fabiola, Canaud, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073075/ https://www.ncbi.nlm.nih.gov/pubmed/27528551 http://dx.doi.org/10.1016/j.kint.2016.06.022 |
Ejemplares similares
-
AAMP is a binding partner of costimulatory human B7-H3
por: Ciprut, Sara, et al.
Publicado: (2022) -
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function
Publicado: (1994) -
The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signaling
por: Popugailo, Andrey, et al.
Publicado: (2023) -
Sorting Nexin 9 facilitates podocin endocytosis in the injured podocyte
por: Sasaki, Yu, et al.
Publicado: (2017) -
Transcription factor 21 expression in injured podocytes of glomerular diseases
por: Usui, Joichi, et al.
Publicado: (2020)